Home Online Features GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine
GC Biopharma Receives MFDS Approval for World’s First Recombinant Anthrax Vaccine
Hand-out
Press Releases
GC Biopharma  
April 9, 2025

GC Biopharma Receives MFDS Approval for World’s First Recombinant Anthrax Vaccine

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX,

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social